| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |